Company Filing History:
Years Active: 2017-2020
Title: Innovations by Xiaoling Puyang in Breast Cancer Treatment
Introduction
Xiaoling Puyang is an accomplished inventor based in Cambridge, MA, specializing in the development of innovative compounds for medical applications. With a focus on breast cancer treatment, she has made significant contributions to the field through her patented inventions.
Latest Patents
Xiaoling Puyang holds two patents, both of which pertain to tetrasubstituted alkene compounds and their therapeutic uses. These compounds are designed for treating breast cancer, particularly targeting ER-positive breast cancer. The patents disclose methods for administering these compounds or their pharmaceutically acceptable salts to subjects in need, ensuring a therapeutically effective amount is delivered. This innovative approach may also benefit patients expressing a mutant ER-α protein.
Career Highlights
Puyang's work at Eisai R&D Management Co., Ltd. has positioned her as a key figure in the pharmaceutical industry. Her research focuses on developing effective treatments for challenging medical conditions, particularly in oncology.
Collaborations
Xiaoling collaborates with esteemed colleagues, including Mark G Bock and Ming-Hong Hao, to advance her research and enhance the impact of her inventions.
Conclusion
Xiaoling Puyang's contributions to breast cancer treatment through her patented innovations highlight her dedication to improving patient outcomes. Her work exemplifies the vital role of inventors in the medical field.